Home › Compare › IPNFF vs MRK

IPNFF vs MRK: Dividend Comparison 2026

IPNFF yields 22988.51% · MRK yields 2.81%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 IPNFF wins by $209253913157569118208.00M in total portfolio value
10 years
IPNFF
IPNFF
● Live price
22988.51%
Share price
$0.01
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$209253913157569118208.00M
Annual income
$207,478,497,165,779,060,000,000,000.00
Full IPNFF calculator →
MRK
Merck & Co. Inc.
● Live price
2.81%
Share price
$118.10
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$57.7K
Annual income
$10,113.78
Full MRK calculator →

Portfolio growth — IPNFF vs MRK

📍 IPNFF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodIPNFFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, IPNFF + MRK cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
IPNFF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

IPNFF
Annual income on $10K today (after 15% tax)
$1,954,022.99/yr
After 10yr DRIP, annual income (after tax)
$176,356,722,590,912,200,000,000,000.00/yr
MRK
Annual income on $10K today (after 15% tax)
$238.95/yr
After 10yr DRIP, annual income (after tax)
$8,596.71/yr
At 15% tax rate, IPNFF beats the other by $176,356,722,590,912,200,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of IPNFF + MRK for your $10,000?

IPNFF: 50%MRK: 50%
100% MRK50/50100% IPNFF
Portfolio after 10yr
$104626956578784559104.00M
Annual income
$103,739,248,582,889,530,000,000,000.00/yr
Blended yield
99.15%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

IPNFF
No analyst data
Altman Z
-161.4
Piotroski
3/9
MRK
Analyst Ratings
24
Buy
12
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+8.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

IPNFF buys
0
MRK buys
8
PoliticianChamberTickerTypeAmountDate
Josh Gottheimer🏢 House$MRK▲ Buy$1,001 - $15,0002026-02-04
Michael McCaul🏢 House$MRK▼ Sell$15,001 - $50,0002026-01-13
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-12-19
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-12-18
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-11-13
Ro Khanna🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-29
Val Hoyle🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-23
Marjorie Taylor Greene🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-28
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-08-14
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-05
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricIPNFFMRK
Forward yield22988.51% ✓2.81%
Annual dividend / share$2.00$3.32 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7% ✓
Portfolio after 10y$209253913157569118208.00M ✓$57.7K
Annual income after 10y$207,478,497,165,779,060,000,000,000.00 ✓$10,113.78
Total dividends collected$209136897216972292096.00M ✓$29.8K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: IPNFF vs MRK ($10,000, DRIP)

YearIPNFF PortfolioIPNFF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$2,309,551$2,298,850.57$11,213$373.04+$2.30M → IPNFF
2$498,668,571$496,197,351.96$12,667$512.06+$498.66M → IPNFF
3$100,661,493,199$100,127,917,828.11$14,439$708.14+$100661.48M → IPNFF
4$18,997,308,529,480$18,889,600,731,757.26$16,640$988.16+$18997308.51M → IPNFF
5$3,352,041,078,501,299$3,331,713,958,374,754.50$19,432$1,394.07+$3352041078.48M → IPNFF
6$553,002,537,294,905,860$549,415,853,340,909,500.00$23,057$1,992.90+$553002537294.88M → IPNFF
7$85,301,813,974,046,130,000$84,710,101,259,140,560,000.00$27,889$2,894.79+$85301813974046.09M → IPNFF
8$12,303,154,006,383,179,000,000$12,211,881,065,430,949,000,000.00$34,518$4,286.29+$12303154006383178.00M → IPNFF
9$1,659,267,282,046,792,600,000,000$1,646,102,907,259,962,700,000,000.00$43,912$6,494.35+$1659267282046792704.00M → IPNFF
10$209,253,913,157,569,130,000,000,000$207,478,497,165,779,060,000,000,000.00$57,714$10,113.78+$209253913157569118208.00M → IPNFF

IPNFF vs MRK: Complete Analysis 2026

IPNFF — Stock

ImagineAR Inc. provides an augmented reality (AR) platform that enables businesses, sports teams, and organizations to create and implement their own AR campaigns with no programming or technology experience. Its products include ImagineAR Augmented Reality Platform that allows the choice of engagement by marker, location, and Web-based activation; ImagineAR.com, an AR-as-a-service platform for desktops; ImagineAR mobile app; ImagineAR SDK/API; ImagineAR White-Label Mobile App; ImagineAR Cloud, a centralized content management system, where AR is securely stored and managed; and WebAR services. The company serves the retail, sports/live events, advertising/promotions, e-sports, and fundraising industries. The company was formerly known as Imagination Park Technologies Inc. and changed its name to ImagineAR Inc. in April 2020. ImagineAR Inc. was incorporated in 2011 and is headquartered in Vancouver, Canada.

Full IPNFF Calculator →

MRK — Healthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this IPNFF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

IPNFF vs SCHDIPNFF vs JEPIIPNFF vs OIPNFF vs KOIPNFF vs MAINIPNFF vs JNJIPNFF vs ABBVIPNFF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.